1. Effect of glucocorticoid deficiency after adrenalectomy on antitumor immunity

   • Yoichiro Hiramoto
   • Keizo Sugimachi

   Original Articles Pages: 157 - 160

2. Lysis of fresh murine mammary tumor cells by syngeneic natural killer cells and lymphokine-activated killer cells

   • Ira H. Ames
   • Christopher E. Gates
   • Russell H. Tomar

   Original Articles Pages: 161 - 168

3. Induction of activated natural killer cells from murine spleen cells primed in vivo and subsequently challenged in vitro with the streptococcal preparation OK432

   • Hiroki Yamaue
   • Masaharu Katsumi
   • Koji Saito

   Original Articles Pages: 169 - 174

4. Antigenicity of UV radiation-induced murine tumors correlates positively with the level of adenosine deaminase activity

   • Sharon Lea Aukerman
   • Isaiah J. Fidler

   Original Articles Pages: 175 - 179

5. The augmentation of tumor-specific immunity using haptenic muramyl dipeptide (MDP) derivatives

   • Haruo Sano
   • Atushi Kosugi
   • Toshiyuki Hamaoka

   Original Articles Pages: 180 - 184

6. Activation of macrophages by ether analogues of lysophospholipids

   • Nobuto Yamamoto
   • Benjamin Z. Ngwenya
   • Ronald A. Pieringer

   Original Articles Pages: 185 - 192

7. Immune response of chimpanzee to purified melanoma 250 kilodalton tumor-associated antigen

   • Gary M. Stuhlmiller
   • Timothy L. Darrow
   • H. F. Seigler

   Original Articles Pages: 193 - 200

8. Studies on macrophage-activating factor (MAF) in antitumor immune responses

   • Hiroto Nakajima
   • Yutaka Izumi
   • Toshiyuki Hamaoka

   Original Articles Pages: 201 - 208

9. In vitro generation of tumour-specific lymphocyte reactivity to colonic carcinoma cells

   • Maria Kuppner
   • Stephen Wilkinson
   • Oleg Eremin

   Original Articles Pages: 209 - 214

10. Some characteristics of the in vivo antitumor immunity exhibited by mice cured of a large MOPC-315 tumor by a low dose of melphalan

    • Edward Barker
    • Margalit B. Mokyr

    Original Articles Pages: 215 - 224

11. Selective cytotoxicity against tumor cells by cisplatin complexed to antitumor antibodies via carboxymethyl dextran

    • B. Schechter
    • R. Pauzner
    • M. Wilchek

    Original Articles Pages: 225 - 230

12. T cell recognition of a tumor-associated glycoprotein and its synthetic carbohydrate epitopes: stimulation of anticancer T cell immunity in vivo

    • Carina M. Henningsson
    • Subnaicker Selvaraj
    • B. Michael Longenecker

    Original Articles Pages: 231 - 241

13. Abrogation of the tumor promoting effect of allogeneic blood transfusion by polyadenylic-polyuridylic acid (poly A-poly U)

    • S. K. Singh
    • R. L. Marquet
    • J. Jeekel

    Original Articles Pages: 242 - 244

14. Enhancement of interleukin-2 release in rats by treatment with bleomycin and Adriamycin in vivo

    • Tarek A. Abdul Hamied
    • John L. Turk

    Original Articles Pages: 245 - 249

15. Requirements for the stimulation of allogeneic T lymphocytes by acute non-lymphoblastic leukaemia cells

    • L. K. Ashman
    • G. W. Kriek
    • D. E. O'Keefe

    Original Articles Pages: 250 - 256

16. Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma

    • Peter Hersey
    • Anne Edwards
    • Gerald Milton

    Original Articles Pages: 257 - 265

17. Interferon-alfa corrects thrombocytosis in patients with myeloproliferative disorders

    • Heinz Ludwig
    • Werner Linkesch
    • Michael Micksche

    Original Articles Pages: 266 - 273

18. Announcement

    Announcement Pages: 274 - 274